title: Psoriatic Erythroderma Caused by Terbinafine: A Possible Pathogenetic Role for IL-23.
authors.affiliation: Department of Dermatology, University of Occupational and Environmental Health, Kitakyūshū, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Oda
authors.affiliation: Department of Dermatology, University of Occupational and Environmental Health, Kitakyūshū, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Sawada
authors.affiliation: Department of Dermatology, University of Occupational and Environmental Health, Kitakyūshū, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Yamaguchi
authors.affiliation: Department of Dermatology, University of Occupational and Environmental Health, Kitakyūshū, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Ohmori
authors.affiliation: Department of Dermatology, University of Occupational and Environmental Health, Kitakyūshū, Japan.
authors.forename: D
authors.initials: D
authors.lastname: Omoto
authors.affiliation: Department of Dermatology, University of Occupational and Environmental Health, Kitakyūshū, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Haruyama
authors.affiliation: Department of Dermatology, University of Occupational and Environmental Health, Kitakyūshū, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Yoshioka
authors.affiliation: Department of Dermatology, University of Occupational and Environmental Health, Kitakyūshū, Japan.
authors.forename: E
authors.initials: E
authors.lastname: Okada
authors.affiliation: Department of Dermatology, University of Occupational and Environmental Health, Kitakyūshū, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Nakamura
mesh_terms: D000369:Aged, 80 and over; D000935:Antifungal Agents / Q000009:adverse effects*; D001623:Betamethasone / Q000008:administration & dosage / Q000031:analogs & derivatives; D001706:Biopsy; D002478:Cells, Cultured; D003873:Dermatitis, Exfoliative / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D003875:Drug Eruptions / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D053759:Interleukin-23 / Q000276:immunology*; D008213:Lymphocyte Activation / Q000187:drug effects; D008775:Methylprednisolone / Q000008:administration & dosage; D009281:Naphthalenes / Q000009:adverse effects*; D011565:Psoriasis / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D012867:Skin / Q000187:drug effects* / Q000276:immunology / Q000473:pathology; D006377:T-Lymphocytes, Helper-Inducer / Q000187:drug effects / Q000276:immunology; D000077291:Terbinafine; D016896:Treatment Outcome
chemical_list: D000935:Antifungal Agents; D005938:Glucocorticoids; D053759:Interleukin-23; D009281:Naphthalenes; C000612965:betamethasone butyrate propionate; D001623:Betamethasone; D000077291:Terbinafine; D008775:Methylprednisolone
keywords: Drug eruption; IL-23; Psoriatic erythroderma; Terbinafine